Back to Report Store Home

Global Ophthalmology Drugs Market to 2023- Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape

  • Published: Aug-2017
  • Report Code: GBIHC450MR
  • Report Format: pdf

Description

List of Tables

Table 1: Ophthalmology Disease Therapeutics Market, Symptoms of Glaucoma, AMD, DME, DR and DES 12

Table 2: Ophthalmology Disease Therapeutics Market, Etiology of Glaucoma, AMD, DME, DR and DES 14

Table 3: Ophthalmology Disease Therapeutics Market, Complications associated with glaucoma, AMD, DR and DES 19

Table 4: Ophthalmology, Global, Epidemiology of Ophthalmologic Disorders, 2017 21

Table 5: Ophthalmology Disease Therapeutics Market, Treatment options available for glaucoma 27

Table 6: Ophthalmology Therapeutics Market, Global, Approved Indications for Lucentis, 2017 29

Table 7: Ophthalmology Therapeutics Market, Global, Approved Indications for Eylea, 2017 31

Table 8: Ophthalmology Therapeutics Market, Global, Off-label Indications for Avastin, 2016 32

Table 9: Ophthalmology Therapeutics Market, Global, Approved Indications for Restasis, 2017 34

Table 10: Ophthalmology Therapeutics Market, Global, Approved Indications for Alphagan, 2017 35

Table 11: Ophthalmology Therapeutics Market, Global, Approved Indications for Lumigan, 2017 36

Table 12: Ophthalmology Therapeutics Market, Global, Approved Indications for Xalatan, 2017 37

Table 13: Opthallmology, Global, Annual Revenue Forecast for Key Products ($bn), 2016-2023 66

Table 14: Ophthalmology Therapeutics Market, Global, Forecast Revenues by Company, 2016–2023 75

Table 15: Ophthalmology Therapeutics Market, Global, Licensing Deals Valued Above $100m, 2006–2017 100

Table 16: Ophthalmology Therapeutics Market, Global, Co-development Deals Valued Above $100m, 2006–2017 110

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards